Back

Early bleeding risk prediction with the PRECISE-HBR score in PCI patients treated with cangrelor: the ICARUS registry

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Optimising outcomes in percutaneous coronary intervention: risk assessment, pharmacotherapy, and clinical insights Stent Thrombosis ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Vincenzo De Sio

The University of Campania Luigi Vanvitelli, Caserta (Italy)

3 More presentations in this session

Presentation thumbnail
CKD severity and high bleeding risk in patients undergoing PCI: stage-specific validation of modified ARC-HBR criteria
Doctor F. Di Muro (Salerno, IT)
Abstract Slides Video
Presentation thumbnail
Association of ANGPTL3, ANGPTL4, and DOCK7 polymorphisms with lipid traits and long-term clinical outcomes in patients undergoing PCI
Doctor Y. Song (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Perfusion balloon prolonged inflation in lipid-rich coronary lesions and slow flow/no-reflow: NIRS-IVUS insights
Doctor S. Izumoto (Miyazaki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising outcomes in percutaneous coronary intervention: risk assessment, pharmacotherapy, and clinical insights

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
External validation of novel bleeding risk scores, ARC-HBR and PRECISE-HBR, in 5116 consecutive ACS patients in clinical practice
29 August 2026
thumbnail
Congress Presentation
Cangrelor versus no cangrelor during percutaneous coronary intervention in hemodynamically unstable patients: a cohort study on benefits and risks
30 August 2024
thumbnail
Congress Presentation
Timing of bleeding and ischemic events after PCI in high and very high bleeding risk patients treated with 1-month DAPT: a patient-level pooled analysis of clinical trials
30 August 2025
thumbnail
Congress Presentation
Differential prognostic value of platelet reactivity and CYP2C19 phenotype in high bleeding risk patients undergoing PCI: insights from the PTRG-DES Registry
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources